Skip to main content

Table 4 Stratified associations between fibrinogen and survival

From: The prognostic role of plasma fibrinogen in adult secondary hemophagocytic lymphohistiocytosis

Subgroups

Tertile 3

Tertile 2

Tertile 1

P for trend

P for interaction

HR (95% CI)

HR (95% CI)

HR (95% CI)

Gender

0.800

 Male

1.00 (Ref)

1.02 (0.84–1.25)

0.80 (0.65–0.98)*

0.068

 

 Female

1.00 (Ref)

1.14 (0.86–1.51)

0.86 (0.65–1.14)

0.458

 

Age ≤ 60 years

0.478

 Yes

1.00 (Ref)

1.00 (0.79–1.28)

0.82 (0.65–1.04)

0.172

 

 No

1.00 (Ref)

1.13 (0.91–1.39)

0.90 (0.73–1.12)

0.480

 

Ferritin > 10,000 ug/L

0.855

 Yes

1.00 (Ref)

0.91 (0.64–1.29)

0.89 (0.64–1.24)

0.499

 

 No

1.00 (Ref)

1.12 (0.94–1.34)

0.80 (0.67–0.97)*

0.140

 

sCD25 > 20,000 ug/L

0.510

 Yes

1.00 (Ref)

0.93 (0.77–1.12)

0.81 (0.67–0.97)*

0.030

 

 No

1.00 (Ref)

1.49 (1.09–2.06)*

0.97 (0.71–1.34)

0.604

 

EBV infection

0.905

 Yes

1.00 (Ref)

0.97 (0.78–1.21)

0.79 (0.64–0.99)*

0.057

 

 No

1.00 (Ref)

1.20 (0.95–1.51)

0.86 (0.67–1.08)

0.531

 

MHLH

0.171

 Yes

1.00 (Ref)

1.06 (0.87–1.29)

0.90 (0.75–1.10)

0.378

 

 No

1.00 (Ref)

1.06 (0.82–1.39)

0.72 (0.55–0.96)*

0.080

 
  1. Analyses were adjusted for age, PLT (platelet), EBV, log10-transform ferritin, MHLH and treatment strategies when they were not stratified variables
  2. Italics indicate statistical significance (P < 0.05)
  3. HR hazard ratio, CI confidence interval
  4. *P < 0.05; **P < 0.001